It was reported that during the first cycle of therapeutic plasma exchange treatment (tpe) using a prismaflex tpe2000 set, the patient became cold; however, treatment was completed without issues.During the second cycle of tpe, the patient became cold again, experienced ¿itchiness¿ and showed signs of hypocalcemia with a ¿funny feeling in the mouth.The patient received ¿2 x2.2mmol¿ of calcium gluconate as a slow push, while the blood was returned.The patient also experienced swelling around the eyes, hives and redness to the eyes and chin.The patient was administered 100mg intravenous hydrocortisone, oral loratadine and intramuscular injection of adrenaline (500mcg) for the events.No additional information is available.
|
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|